Validation of an automated assay for the measurement of cupric reducing antioxidant capacity in serum of dogs

BMC Veterinary Research

Volumn 12, Issue 1, 2016, Pages

  Rubio, Camila Peres ^a   Tvarijonaviciute, Asta ^a,b   Martinez Subiela, Silvia ^a   Hernández Ruiz, Josefa ^a   Cerón, José Joaquin ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Bathocuproinedisulfonic acid; CUPRAC; Dogs; Oxidative stress; Validation

Indexed keywords

ANTIOXIDANT; BATHOCUPROINE SULFONATE; COPPER; PHENANTHROLINE DERIVATIVE;

ANIMAL; AUTOMATION; BLOOD; BLOOD ANALYSIS; DEVICES; DOG; METABOLISM; OXIDATION REDUCTION REACTION; REPRODUCIBILITY; STANDARDS; VALIDATION STUDY; VETERINARY;

ANIMALS; ANTIOXIDANTS; AUTOMATION; BLOOD CHEMICAL ANALYSIS; COPPER; DOGS; OXIDATION-REDUCTION; PHENANTHROLINES; REPRODUCIBILITY OF RESULTS;

EID: 84976907500     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/s12917-016-0760-2     Document Type: Article

References (33)

1. López-Alarcón C, Denicola A. Evaluating the antioxidant capacity of natural products: A review on chemical and cellular-based assays. Anal Chim Acta. 2013;763:1-10.
2. Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 2015;4:180-3.
3. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci. 1993;84:407-12.
4. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem. 1996;239:70-6.
5. Rice-Evans CA, Diplock AT, Symons MC. Techniques in free radical research. Laboratory techniques in biochemistry and molecular biology. London: Elsevier; 1991.
6. Bartosz G. Non-enzymatic antioxidant capacity assays: limitations of use in biomedicine. Free Radic Res. 2010;44:711-20.
7. Glantzounis GK, Tselepis AD, Tambaki AP, Trikalinos TA, Manataki AD, Galaris DA, Tsimoyiannis EC, Kappas AM. Laparoscopic surgery-induced changes in oxidative stress markers in human plasma. Surg Endosc. 2001;15:1315-9.
8. Zulfikaroglu B, Koc M, Soran A, Isman FK, Cinel I. Evaluation of oxidative stress in laparoscopic cholecystectomy. Surg Today. 2002;32:869-74.
9. Hopps E, Canino B, Montana M, Lo Presti R, Averna MR, Caimi G. Behavior of the total antioxidant status in a group of subjects with metabolic syndrome. Diabetes Metab Syndr. 2014;8:166-9.
10. Mohieldein AH, Hasan M, Al-Harbi KK, Alodailah SS, Azahrani RM, Al-Mushawwah SA. Dyslipidemia and reduced total antioxidant status in young adult Saudis with prediabetes. Diabetes Metab Syndr. 2015;9:287-91.
11. Lee JY. Evaluation of the total oxidant and antioxidant status of the plasma of dogs anaesthetised with isoflurane. Vet Rec. 2013;173:96.
12. Lee JY, Kim MC. Comparison of oxidative stress status in dogs undergoing laparoscopic and open ovariectomy. J Vet Med Sci. 2014;76:273-6.
13. Martínez-Subiela S, Bernal LJ, Tvarijonaviciute A, Garcia-Martinez JD, Tecles F, Cerón JJ. Canine demodicosis: the relationship between response to treatment of generalised disease and markers for inflammation and oxidative status. Vet Dermatol. 2014;25:72-e24.
14. Kocaturk M, Tvarijonaviciute A, Martinez-Subiela S, Tecles F, Eralp O, Yilmaz Z, Ceron JJ. Inflammatory and oxidative biomarkers of disease severity in dogs with parvoviral enteritis. J Small Anim Pract. 2015;56:119-24.
15. Winter JL, Barber LG, Freeman L, Griessmayr PC, Milbury PE, Blumberg JB. Antioxidant status and biomarkers of oxidative stress in dogs with lymphoma. J Vet Intern Med. 2009;23:311-6.
16. Apak R, Güçlü K, Özyürek M, Karademir SEN, Altun M. Total antioxidant capacity assay of human serum using copper (II)-neocuproine as chromogenic oxidant: the CUPRAC method. Free Radic Res. 2005;39:949-61.
17. Güçlü K, Sözgen K, Tütem E, Özyürek M, Apak R. Spectrophotometric determination of ascorbic acid using copper (II)-neocuproine reagent in beverages and pharmaceuticals. Talanta. 2005;65:1226-32.
18. Özyürek M, Güçlü K, Bektaşoğlu B, Apak R. Spectrophotometric determination of ascorbic acid by the modified CUPRAC method with extractive separation of flavonoids-La (III) complexes. Anal Chim Acta. 2007;588:88-95.
19. Campos C, Guzmán R, López-Fernández E, Casado Á. Evaluation of the copper (II) reduction assay using bathocuproinedisulfonic acid disodium salt for the total antioxidant capacity assessment: The CUPRAC-BCS assay. Anal Biochem. 2009;392:37-44.
20. Tiwari G, Tiwari R. Bioanalytical method validation: An updated review. Pharm Methods. 2010;1:25-38.
21. Tvarijonaviciute A, Tecles F, Caldin M, Tasca S, Cerón J.-Validation of spectrophotometric assays for serum paraoxonase type-1 measurement in dogs. Am J Vet Res. 2012;73:34-41.
22. Kjelgaard-Hansen M, Jacobsen S. Assay validation and diagnostic applications of major acute-phase protein testing in companion animals. Clin Lab Med. 2011;31:51-70.
23. Martínez-Subiela S, Cerón JJ. Effects of hemolysis, lipemia, hyperbilirrubinemia, and anticoagulants in canine C-reactive protein, serum amyloid A, and ceruloplasmin assays. Can Vet J. 2005;46:625-9.
24. Ohta H, Sunden Y, Yokoyama N, Osuga T, Lim SL, Tamura Y, Morishita K, Nakamura K, Yamasaki M, Takiguchi M. Expression of apical junction complex proteins in duodenal mucosa of dogs with inflammatory bowel disease. Am J Vet Res. 2014;75:746-51.
25. Washabau RJ, Day MJ, Willard MD, Hall EJ, Jergens AE, Mansell J, Minami T, Bilzer TW. Endoscopic, biopsy, and histopathologic guidelines for the evaluation of gastrointestinal inflammation in companion animals. J Vet Intern Med. 2010;24:10-26.
26. Rossi G, Cerquetella M, Antonelli E, Pengo G, Magi GE, Villanacci V, Rostami-Nejad M, Spaterna A, Bassotti G. The importance of histologic parameters of lacteal involvement in cases of canine lymphoplasmacytic enteritis. Gastroenterol Hepatol Bed Bench. 2015;8:33-41.
27. Gosmaro F, Bagnati M, Berto S, Bellomo G, Prenesti E. Measurement of total antioxidant capacity of human plasma: setting and validation of the CUPRAC-BCS method on routine apparatus ADVIA 2400. Talanta. 2013;115:526-32.
28. Sutton A, Dawson H, Hoff B, Grift E, Shoukri M. Analyte comparisons between 2 clinical chemistry analyzers. Can Vet J. 1999;40:255.
29. Baral R, Morton J, Dhand NK, Krockenberger MB, Govendir M. Repeatability of results from three in-house biochemistry analyzers and a commercial laboratory analyzer used in small animal practice. Comp Clin Path. 2015;24:755-765.
30. Jackson M, Jewell D. Metabolomic and clinical disturbances in canine inflammatory bowel disease. FASEB J. 2015;29:265-7.
31. Pavlick KP, Laroux FS, Fuseler J, Wolf RE, Gray L, Hoffman J, Grisham MB. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease 1,2. Free Radic Biol Med. 2002;33:311-22.
32. Koutroubakis I, Malliaraki N, Dimoulios PD, Karmiris K, Castanas E, Kouroumalis EA. Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease. Dig Dis Sci. 2004;49:1433-7.
33. Minamoto Y, Otoni CC, Steelman SM, Büyükleblebici O, Steiner JM, Jergens AE, Suchodolski JS. Alteration of the fecal microbiota and serum metabolite profiles in dogs with idiopathic inflammatory bowel disease. Gut Microbes. 2015;6:33-47.